Related Experiment Video
Updated: Jun 20, 2026
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Economic burden of contrast-induced nephropathy: implications for prevention strategies
Insights
Contrast-induced nephropathy (CIN) significantly impacts patient health and incurs high costs. This study estimates the average in-hospital cost at $10,345 and the 1-year cost at $11,812 per patient.
Area of Science:
- Nephrology
- Healthcare Economics
- Interventional Cardiology
Background:
- Contrast-induced nephropathy (CIN) is a leading cause of hospital-acquired acute kidney injury.
- CIN is associated with increased patient morbidity, mortality, and healthcare utilization.
Purpose of the Study:
- To estimate the direct healthcare costs associated with CIN.
- To quantify the in-hospital and one-year economic burden of CIN.
Main Methods:
- A decision analytic model was developed.
- Data were sourced from a comprehensive literature review.
Main Results:
- The average in-hospital cost for CIN is estimated at $10,345.
- The average one-year cost for managing CIN is estimated at $11,812.
- Patients with CIN face higher risks of adverse events, prolonged dialysis, extended hospital stays, and increased mortality.
Conclusions:
- The economic burden of CIN is substantial.
- Targeted interventions to reduce CIN incidence are crucial for mitigating healthcare costs.
- Reducing CIN can lead to significant savings in healthcare expenditure.
Abstract:
SUMMARY Contrast-induced nephropathy (CIN) is the third most common cause of hospital-acquired acute renal failure. There is increasing evidence that CIN has a significant adverse impact on patient morbidity and mortality. The objective of this study was to estimate the in-hospital and 1-year direct healthcare costs related to CIN. Using the values obtained from the literature review, a decision analytic model was developed to estimate the in-hospital and 1-year costs of CIN. Patients who develop CIN are more likely to experience adverse events, to undergo prolonged dialysis, to have longer hospital and intensive care unit stays and to have higher mortality rates. The average in-hospital cost of CIN is $10,345. The 1-year cost of treating a patient with CIN is $11,812. Overall, the economic burden associated with CIN is high. Adopting targeted interventions will reduce the incidence of CIN and its overall economic burden.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:28Chronic Kidney Disease III: Interprofessional Care
01:24Nephrotic Syndrome III : Nursing Management
01:24Nephrotic Syndrome I : Introduction
01:18Chronic Kidney Disease IV: Nursing Management
01:28Diabetic Nephropathy